{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T13:12:17Z","timestamp":1774098737534,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005693","name":"Parent Project Muscular Dystrophy","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005693","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Growth and Bone Foundation at Children\u2019s Hospital Los Angeles"},{"name":"The Skirball Fellowship Research Award at the Children\u2019s Hospital Los Angeles"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00198-019-05077-5","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T08:02:25Z","timestamp":1565164945000},"page":"2283-2288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluating RANKL and OPG levels in patients with Duchenne muscular dystrophy"],"prefix":"10.1007","volume":"30","author":[{"given":"S.","family":"Akhtar Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Olney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ramos-Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ryabets-Lienhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Georgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pitukcheewanont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"issue":"3","key":"5077_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/s-0032-1329199","volume":"32","author":"KM Flanigan","year":"2012","unstructured":"Flanigan KM (2012) The muscular dystrophies. Semin Neurol 32(3):255\u2013263","journal-title":"Semin Neurol"},{"issue":"11","key":"5077_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/01.phm.0000184156.98671.d0","volume":"84","author":"B Balaban","year":"2005","unstructured":"Balaban B, Matthews DJ, Clayton GH, Carry T (2005) Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. Am J Phys Med Rehabil 84(11):843\u2013850","journal-title":"Am J Phys Med Rehabil"},{"issue":"8","key":"5077_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1468-1331.2004.00866.x","volume":"11","author":"O Yilmaz","year":"2004","unstructured":"Yilmaz O, Karaduman A, Topaloglu H (2004) Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. Eur J Neurol 11(8):541\u2013544","journal-title":"Eur J Neurol"},{"issue":"4","key":"5077_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347\u2013361","journal-title":"Lancet Neurol"},{"issue":"9\u201310","key":"5077_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.nmd.2014.06.213","volume":"24","author":"C Tian","year":"2014","unstructured":"Tian C, Wong B, Hornung L, Khoury J, Miller L, Bange J, Rybalsky I, Rutter M (2014) Age-specific prevalence of osteoporosis and frequency of poor bone health indices in Duchenne muscular dystrophy. Neuromuscul Disord 24(9\u201310):857","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"5077_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","volume":"5","author":"BF Boyce","year":"2007","unstructured":"Boyce BF, Xing L (2007) The RANKL\/RANK\/OPG pathway. Curr Osteoporos Rep 5(3):98\u2013104","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"5077_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys 473(2):139\u2013146","journal-title":"Arch Biochem Biophys"},{"issue":"Suppl 1","key":"5077_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2165","volume":"9","author":"BF Boyce","year":"2007","unstructured":"Boyce BF, Xing L (2007) Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9(Suppl 1):S1","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5077_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/art.22433","volume":"56","author":"KA Rouster-Stevens","year":"2007","unstructured":"Rouster-Stevens KA, Langman CB, Price HE, Seshadri R, Shore RM, Abbott K, Pachman LM (2007) RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis. Arthritis Rheum 56(3):977\u2013983","journal-title":"Arthritis Rheum"},{"key":"5077_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1546-0096-8-30","volume":"8","author":"G Lien","year":"2010","unstructured":"Lien G, Ueland T, Godang K, Selvaag AM, Forre OT, Flato B (2010) Serum levels of osteoprotegerin and receptor activator of nuclear factor -kappaB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study. Pediatr Rheumatol Online J 8:30","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"5077_CR11","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00198-015-3422-5","volume":"27","author":"C Tsentidis","year":"2016","unstructured":"Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K (2016) Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Osteoporos Int 27(4):1631\u20131643","journal-title":"Osteoporos Int"},{"issue":"10","key":"5077_CR12","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00467-010-1583-1","volume":"25","author":"A Wasilewska","year":"2010","unstructured":"Wasilewska A, Rybi-Szuminska A, Zoch-Zwierz W (2010) Serum RANKL, osteoprotegerin (OPG), and RANKL\/OPG ratio in nephrotic children. Pediatr Nephrol 25(10):2067\u20132075","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"5077_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1365-2265.2012.04392.x","volume":"77","author":"RC Olney","year":"2012","unstructured":"Olney RC, Permuy JW, Prickett TC, Han JC, Espiner EA (2012) Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP) predicts height velocity in healthy children. Clin Endocrinol 77(3):416\u2013422","journal-title":"Clin Endocrinol"},{"issue":"2","key":"5077_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","volume":"17","author":"NJ Crabtree","year":"2014","unstructured":"Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon CM (2014) Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD pediatric official positions. J Clin Densitom 17(2):225\u2013242","journal-title":"J Clin Densitom"},{"issue":"8","key":"5077_CR15","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/jbmr.410","volume":"26","author":"A Rufo","year":"2011","unstructured":"Rufo A, Del Fattore A, Capulli M, Carvello F, De Pasquale L, Ferrari S, Pierroz D, Morandi L, De Simone M, Rucci N, Bertini E, Bianchi ML, De Benedetti F, Teti A (2011) Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res 26(8):1891\u20131903","journal-title":"J Bone Miner Res"},{"issue":"2","key":"5077_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.bone.2010.09.011","volume":"48","author":"WR Nakagaki","year":"2011","unstructured":"Nakagaki WR, Bertran CA, Matsumura CY, Santo-Neto H, Camilli JA (2011) Mechanical, biochemical and morphometric alterations in the femur of mdx mice. Bone 48(2):372\u2013379","journal-title":"Bone"},{"issue":"9","key":"5077_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/adc.88.9.795","volume":"88","author":"MS Fewtrell","year":"2003","unstructured":"Fewtrell MS (2003) Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls. Arch Dis Child 88(9):795\u2013798","journal-title":"Arch Dis Child"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05077-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05077-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05077-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T23:41:56Z","timestamp":1596670916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05077-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["5077"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05077-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"assertion":[{"value":"29 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Pisit Pitukcheewanont had research funding from Ultragenyx, Amgen, and Shire; salary from Ascendis Pharma. Anna Ryabets-Lienhard has research funding from Ultragenyx, Amgen, and Shire. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee. Informed consent was obtained for all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}